Treatment-related toxicities associated with hospitalization in children, adolescents, and young adults with acute lymphoblastic leukemia: population level analysis
- 23 August 2022
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 63 (13) , 1-9
Abstract
Treatment-related toxicities (TRTs) are a potential cause of survival disparities in patients with acute lymphoblastic leukemia (ALL). We aimed to identify the most frequent TRTs associated with hospitalizations at a population level in children, adolescents and young adults (AYAs). We used the California Cancer Registry linked to a statewide hospital discharge database to identify children and AYAs with TRTs within 3 years of diagnosis. We assessed the frequency of TRTs, length of stay (LOS), admission rates associated with TRTs and TRTs impact on survival. Febrile neutropenia, hypertension, and thrombocytopenia were the most common TRTs for both children and AYAs. AYAs had longer median LOS compared to children for most toxicities. AYAs at non-specialized cancer centers (SCCs) had higher frequency of admissions associated with TRTs compared to non-SCC. Cardiovascular, respiratory, gastrointestinal, renal, and infectious TRTs were associated with worse survival. This study demonstrates the burden of TRTs in patients with ALL.Keywords
Funding Information
- University of California Davis Department of Pediatrics Resident and Fellow Grant
This publication has 29 references indexed in Scilit:
- Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adultsCancer, 2016
- A retrospective analysis of treatment‐related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemiaCancer Medicine, 2015
- Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupPediatric Blood & Cancer, 2015
- Children's Hospitals with Shorter Lengths of Stay Do Not Have Higher Readmission RatesThe Journal of Pediatrics, 2013
- Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemiaPediatric Blood & Cancer, 2010
- Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study groupLeukemia, 2009
- What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studiesBlood, 2008
- Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95Blood, 2008
- Site of Oncologic Specialty Care for Older Adolescents in UtahJournal of Clinical Oncology, 2007
- Obesity and hypertension among children after treatment for acute lymphoblastic leukemiaCancer, 2007